These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7075304)

  • 21. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raynaud's phenomenon and systemic sclerosis.
    Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
    Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary diffusing capacity disturbances are related to nailfold capillary changes in patients with Raynaud's phenomenon with and without an underlying connective tissue disease.
    Groen H; Wichers G; ter Borg EJ; van der Mark TW; Wouda AA; Kallenberg CG
    Am J Med; 1990 Jul; 89(1):34-41. PubMed ID: 2368791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thermography of collagen diseases with Raynaud's phenomenon].
    Watanabe I; Sagawa A; Baba Y; Atsumi T; Jodo S; Amazaki Y; Nakabayashi T; Mukai M; Fujisaku A; Nakagawa S
    Ryumachi; 1991 Apr; 31(2):167-74. PubMed ID: 1925795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J; Rovenský J; Tauchmannová H; Zitnan D
    Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in the parameters of respiratory function tests in Raynaud's disease].
    Kozielski J; Ziora D; Dobosz J; Oklek K
    Pol Arch Med Wewn; 1992 Jun; 87(6):341-4. PubMed ID: 1408992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can sensation of cold hands predict Raynaud's phenomenon or paraesthesia?
    Carlsson D; Wahlström J; Burström L; Hagberg M; Lundström R; Pettersson H; Nilsson T
    Occup Med (Lond); 2018 Jun; 68(5):314-319. PubMed ID: 29750280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative assessment of the effects of vasodilators on peripheral vascular reactivity in patients with systemic scleroderma and Raynaud's phenomenon: color Doppler flow imaging study.
    Aikimbaev KS; Oğuz M; Ozbek S; Demirtaş M; Birand A; Batyraliev T
    Angiology; 1996 May; 47(5):475-80. PubMed ID: 8644944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiological classification of Raynaud's phenomenon.
    Nilsen KH
    Br J Dermatol; 1980 Jan; 102(1):1-5. PubMed ID: 7378276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Manometric assessment of oesophageal involvement in progressive systemic sclerosis, morphoea and Raynaud's disease.
    Weihrauch TR; Korting GW
    Br J Dermatol; 1982 Sep; 107(3):325-32. PubMed ID: 7115611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Raynaud's phenomenon of the lung. A reality both in primary and secondary Raynaud syndrome.
    Vergnon JM; Barthélémy JC; Riffat J; Boissier C; Claudy A; Emonot A
    Chest; 1992 May; 101(5):1312-7. PubMed ID: 1582290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cold hypersenstivity in Raynaud's phenomenon.
    Jamieson GG; Ludbrook J; Wilson A
    Circulation; 1971 Aug; 44(2):254-64. PubMed ID: 4327362
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
    Seibold JR; Harris JN
    J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin and Raynaud's phenomenon.
    Seibold JR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S95-8. PubMed ID: 2412070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An imbalance in plasma prostanoids in patients with Raynaud's phenomenon and pulmonary vasospasm.
    Sakamoto K; Houya I; Inoue K; Tanaka M; Suzuki T; Sakamoto Y; Matsuo H
    Eur Respir J; 1999 Jan; 13(1):137-44. PubMed ID: 10836338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular function at rest and during Raynaud's phenomenon in patients with scleroderma.
    Siegel RJ; O'Connor B; Mena I; Criley JM
    Am Heart J; 1984 Dec; 108(6):1469-76. PubMed ID: 6507243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of vascular reactivity in scleroderma: new insights into Raynaud's phenomenon.
    Flavahan NA
    Rheum Dis Clin North Am; 2008 Feb; 34(1):81-7; vii. PubMed ID: 18329534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmapheresis in Raynaud's phenomenon in systemic sclerosis: a microcirculatory study.
    Jacobs MJ; Jörning PJ; Van Rhede van der Kloot EJ; Kitslaar PJ; Lemmens HA; Slaaf DW; Reneman RS
    Int J Microcirc Clin Exp; 1991 Feb; 10(1):1-11. PubMed ID: 2019479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.
    Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD
    Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pulmonary changes in patients with "primary" and "secondary" Raynaud's phenomenon].
    Emter M; Alexander K; Meissner E; Fabel H
    Vasa Suppl; 1987; 20():391-3. PubMed ID: 3480603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.